We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$347M
AUM Growth
+$3.28M
Cap. Flow
+$7.65M
Cap. Flow %
2.2%
Top 10 Hldgs %
56.15%
Holding
100
New
3
Increased
56
Reduced
11
Closed
7

Top Buys

Rank Stock Value
1
ADPT icon
Adaptive Biotechnologies
ADPT
+$2.06M
2
FIS icon
Fidelity National Information Services
FIS
+$1.81M
3
NVDA icon
NVIDIA
NVDA
+$981K
4
ZION icon
Zions Bancorporation
ZION
+$851K
5
MSFT icon
Microsoft
MSFT
+$581K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.09M
2
ALGN icon
Align Technology
ALGN
+$1.82M
3
UNP icon
Union Pacific
UNP
+$1.01M
4
MRK icon
Merck
MRK
+$1.01M
5
SWK icon
Stanley Black & Decker
SWK
+$726K

Sector Composition

Rank Sector Weight
1 Healthcare 34.66%
2 Industrials 16.98%
3 Technology 14.23%
4 Energy 10.57%
5 Financials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$307B
$54.9M 15.81%
683,306
-12,576
-2% -$1.01M
UNP icon
2
Union Pacific
UNP
$176B
$24.1M 6.95%
149,000
-6,000
-4% -$1.01M
XOM icon
3
ExxonMobil
XOM
$615B
$20.1M 5.79%
284,796
-2,500
-0.9% -$181K
TMO icon
4
Thermo Fisher Scientific
TMO
$196B
$16.7M 4.82%
57,495
+876
+2% +$251K
ROP icon
5
Roper Technologies
ROP
$36.6B
$16.7M 4.8%
46,738
+537
+1% +$195K
JPM icon
6
JPMorgan Chase
JPM
$901B
$13.8M 3.97%
117,165
+2,624
+2% +$297K
AME icon
7
Ametek
AME
$53.9B
$13.8M 3.97%
150,055
+1,643
+1% +$145K
MSFT icon
8
Microsoft
MSFT
$2.99T
$12.1M 3.5%
87,361
+4,225
+5% +$581K
CELG
9
DELISTED
Celgene Corp
CELG
$11.6M 3.35%
116,987
+321
+0.3% +$30.5K
MUR icon
10
Murphy Oil
MUR
$5.28B
$11.1M 3.2%
501,855
-3,000
-0.6% -$64.5K
AMT icon
11
American Tower
AMT
$77.8B
$8.85M 2.55%
40,000
– –
TECH icon
12
Bio-Techne
TECH
$11.2B
$6.45M 1.86%
131,908
+4,180
+3% +$210K
PCH
13
DELISTED
PotlatchDeltic
PCH
$6.23M 1.79%
151,661
– –
PH icon
14
Parker-Hannifin
PH
$120B
$5.95M 1.71%
32,935
-80
-0.2% -$13.6K
COO icon
15
Cooper Companies
COO
$14B
$4.75M 1.37%
64,000
– –
GPN icon
16
Global Payments
GPN
$22.5B
$4.71M 1.36%
29,607
+64
+0.2% +$10.4K
AMZN icon
17
Amazon
AMZN
$2.69T
$4.65M 1.34%
53,540
+4,640
+9% +$430K
IDXX icon
18
Idexx Laboratories
IDXX
$44.5B
$4.52M 1.3%
16,635
+47
+0.3% +$13.1K
AAPL icon
19
Apple
AAPL
$4.8T
$4.46M 1.29%
79,732
+6,776
+9% +$354K
BA icon
20
Boeing
BA
$165B
$4.33M 1.25%
11,383
+1,616
+17% +$578K
V icon
21
Visa
V
$686B
$3.75M 1.08%
21,776
+2,180
+11% +$388K
MUSA icon
22
Murphy USA
MUSA
$11.5B
$3.7M 1.07%
43,413
– –
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$4.3T
$3.64M 1.05%
59,580
+20
+0% +$1.18K
NVDA icon
24
NVIDIA
NVDA
$4.92T
$3.17M 0.91%
728,880
+233,200
+47% +$981K
FIS icon
25
Fidelity National Information Services
FIS
$21.8B
$2.96M 0.85%
22,312
+13,661
+158% +$1.81M
1
2 3 4

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

Aristotle Atlantic Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Aristotle Atlantic Partners held 100 positions worth $347M, up 0.95% from $344M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Aristotle Atlantic Partners's Q3 2019 filing shows 3 new, 56 increased, 11 reduced and 7 closed positions. Its largest new stake was Adaptive Biotechnologies: 50,459 shares worth $1.56M. The largest sale was Allergan plc, an estimated $2.09M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 36% a quarter earlier, followed by Industrials and Technology.

  • Aristotle Atlantic Partners's largest Q3 2019 buy was Adaptive Biotechnologies: 50,459 shares worth $1.56M.
  • Aristotle Atlantic Partners added most to Fidelity National Information Services in Q3 2019, an estimated $1.81M increase.
  • Aristotle Atlantic Partners's biggest Q3 2019 reduction was Union Pacific, cutting an estimated $1.01M.
  • Aristotle Atlantic Partners fully exited Allergan plc in Q3 2019, selling an estimated $2.09M.
  • Aristotle Atlantic Partners's ten largest holdings make up 56% of its $347M portfolio in Q3 2019.
  • Aristotle Atlantic Partners opened 3 new positions and closed 7 in Q3 2019.
  • Aristotle Atlantic Partners's portfolio value rose 0.95% quarter-over-quarter to $347M.

Based on Aristotle Atlantic Partners's 13F filing for Q3 2019, filed 14 Nov 2019.